+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Osteoarthritis Pain Drug Market Research Report by Drug Class, by Route of Administration, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

  • ID: 4995456
  • Report
  • July 2021
  • Region: Global
  • 180 pages
  • 360iResearch™
UP TO OFF
until Sep 30th 2021
The Global Osteoarthritis Pain Drug Market will Grow to USD 9,684.59 Million by 2026, at a CAGR of 6.28%

FEATURED COMPANIES

  • Alkem Laboratories
  • Anika Therapeutics, Inc.
  • Bioventus, Inc.
  • Ferring B.V.
  • Horizon Pharma plc
  • Pfizer Inc
The Global Osteoarthritis Pain Drug Market size was estimated at USD 6,718.34 Million in 2020 and expected to reach USD 7,117.82 Million in 2021, at a Compound Annual Growth Rate (CAGR) 6.28% to reach USD 9,684.59 Million by 2026.



Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Osteoarthritis Pain Drug to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Drug Class, the Osteoarthritis Pain Drug Market was examined across Corticosteriods, NSAIDs, and Viscosupplementation.
  • Based on Distribution Channel, the Osteoarthritis Pain Drug Market was examined across Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies.
  • Based on Route of Administration, the Osteoarthritis Pain Drug Market was examined across Oral, Parenteral, and Topical.
  • Based on Geography, the Osteoarthritis Pain Drug Market was examined across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas was further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific was further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, and Thailand. The Europe, Middle East & Africa was further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. This ongoing research amplifies this research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Osteoarthritis Pain Drug Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Osteoarthritis Pain Drug Market, including Alkem Laboratories, Anika Therapeutics, Inc., Bioventus, Inc., Chugai Pharmaceutical Co., Limited, Ferring B.V., Flexion Therapeutics, Inc., Horizon Pharma plc, Pfizer Inc, Sanofi S.A., and Zimmer Biomet Holdings, Inc.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Osteoarthritis Pain Drug Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Osteoarthritis Pain Drug Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Osteoarthritis Pain Drug Market?
4. What is the competitive strategic window for opportunities in the Global Osteoarthritis Pain Drug Market?
5. What are the technology trends and regulatory frameworks in the Global Osteoarthritis Pain Drug Market?
6. What is the market share of the leading vendors in the Global Osteoarthritis Pain Drug Market?
7. What modes and strategic moves are considered suitable for entering the Global Osteoarthritis Pain Drug Market?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Alkem Laboratories
  • Anika Therapeutics, Inc.
  • Bioventus, Inc.
  • Ferring B.V.
  • Horizon Pharma plc
  • Pfizer Inc
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. Drug Class Outlook
3.4. Distribution Channel Outlook
3.5. Route of Administration Outlook
3.6. Geography Outlook
3.7. Competitor Outlook

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of osteoarthritis and growing population susceptible to osteoarthritis
5.1.1.2. Rising number of sports injuries
5.1.1.3. Increasing consumer awareness level and improved technology
5.1.2. Restraints
5.1.2.1. High cost of drug development and severe side-effects
5.1.3. Opportunities
5.1.3.1. Advancement in the healthcare and pharmaceutical sectors
5.1.3.2. Ongoing research and development
5.1.3.3. Collaborations between governments and private companies for the supply of drugs
5.1.4. Challenges
5.1.4.1. Presence of counterfeit and cheap quality drugs
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry

6. Osteoarthritis Pain Drug Market, by Drug Class
6.1. Introduction
6.2. Corticosteriods
6.3. NSAIDs
6.4. Viscosupplementation

7. Osteoarthritis Pain Drug Market, by Distribution Channel
7.1. Introduction
7.2. Hospital Pharmacies
7.3. Online Pharmacies
7.4. Retail Pharmacies

8. Osteoarthritis Pain Drug Market, by Route of Administration
8.1. Introduction
8.2. Oral
8.3. Parenteral
8.4. Topical

9. Americas Osteoarthritis Pain Drug Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Osteoarthritis Pain Drug Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Thailand

11. Europe, Middle East & Africa Osteoarthritis Pain Drug Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion

13. Company Usability Profiles
13.1. Alkem Laboratories
13.2. Anika Therapeutics, Inc.
13.3. Bioventus, Inc.
13.4. Chugai Pharmaceutical Co., Limited
13.5. Ferring B.V.
13.6. Flexion Therapeutics, Inc.
13.7. Horizon Pharma plc
13.8. Pfizer Inc
13.9. Sanofi S.A.
13.10. Zimmer Biomet Holdings, Inc.

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing

List of Figures
FIGURE 1. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, 2020 VS 2026 (USD MILLION)
FIGURE 2. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DRUG CLASS, 2020 (USD MILLION)
FIGURE 3. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 (USD MILLION)
FIGURE 4. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2020 (USD MILLION)
FIGURE 5. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 6. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 7. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET: MARKET DYNAMICS
FIGURE 8. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 9. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DRUG CLASS, 2020 VS 2026 (%)
FIGURE 10. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DRUG CLASS, 2020 VS 2026 (USD MILLION)
FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DRUG CLASS, 2026
FIGURE 12. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY CORTICOSTERIODS, 2018-2026 (USD MILLION)
FIGURE 13. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY CORTICOSTERIODS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 14. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY NSAIDS, 2018-2026 (USD MILLION)
FIGURE 15. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY NSAIDS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 16. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY VISCOSUPPLEMENTATION, 2018-2026 (USD MILLION)
FIGURE 17. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY VISCOSUPPLEMENTATION, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 18. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 VS 2026 (%)
FIGURE 19. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 VS 2026 (USD MILLION)
FIGURE 20. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2026
FIGURE 21. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2026 (USD MILLION)
FIGURE 22. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY HOSPITAL PHARMACIES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 23. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ONLINE PHARMACIES, 2018-2026 (USD MILLION)
FIGURE 24. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ONLINE PHARMACIES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 25. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY RETAIL PHARMACIES, 2018-2026 (USD MILLION)
FIGURE 26. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY RETAIL PHARMACIES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 27. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2020 VS 2026 (%)
FIGURE 28. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2020 VS 2026 (USD MILLION)
FIGURE 29. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2026
FIGURE 30. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ORAL, 2018-2026 (USD MILLION)
FIGURE 31. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ORAL, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 32. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PARENTERAL, 2018-2026 (USD MILLION)
FIGURE 33. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PARENTERAL, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 34. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY TOPICAL, 2018-2026 (USD MILLION)
FIGURE 35. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY TOPICAL, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 36. AMERICAS OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
FIGURE 37. AMERICAS OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 38. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY GEOGRAPHY, 2026
FIGURE 39. ARGENTINA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 40. BRAZIL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 41. CANADA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 42. MEXICO OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 43. UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 44. ASIA-PACIFIC OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
FIGURE 45. ASIA-PACIFIC OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 46. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY GEOGRAPHY, 2026
FIGURE 47. AUSTRALIA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 48. CHINA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 49. INDIA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 50. INDONESIA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 51. JAPAN OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 52. MALAYSIA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 53. PHILIPPINES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 54. SINGAPORE OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 55. SOUTH KOREA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 56. THAILAND OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 57. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
FIGURE 58. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 59. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY GEOGRAPHY, 2026
FIGURE 60. FRANCE OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 61. GERMANY OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 62. ITALY OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 63. NETHERLANDS OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 64. QATAR OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 65. RUSSIA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 66. SAUDI ARABIA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 67. SOUTH AFRICA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 68. SPAIN OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 69. UNITED ARAB EMIRATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 70. UNITED KINGDOM OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 71. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET: FPNV POSITIONING MATRIX
FIGURE 72. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 73. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET, BY TYPE

List of Tables
TABLE 1. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 4. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD MILLION)
TABLE 5. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY CORTICOSTERIODS, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 6. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY NSAIDS, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 7. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY VISCOSUPPLEMENTATION, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 8. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 9. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY HOSPITAL PHARMACIES, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 10. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ONLINE PHARMACIES, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 11. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY RETAIL PHARMACIES, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 12. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD MILLION)
TABLE 13. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ORAL, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 14. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PARENTERAL, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 15. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY TOPICAL, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 16. AMERICAS OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 17. AMERICAS OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD MILLION)
TABLE 18. AMERICAS OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 19. AMERICAS OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD MILLION)
TABLE 20. ARGENTINA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD MILLION)
TABLE 21. ARGENTINA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 22. ARGENTINA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD MILLION)
TABLE 23. BRAZIL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD MILLION)
TABLE 24. BRAZIL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 25. BRAZIL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD MILLION)
TABLE 26. CANADA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD MILLION)
TABLE 27. CANADA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 28. CANADA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD MILLION)
TABLE 29. MEXICO OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD MILLION)
TABLE 30. MEXICO OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 31. MEXICO OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD MILLION)
TABLE 32. UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 33. UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD MILLION)
TABLE 34. UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 35. UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD MILLION)
TABLE 36. ASIA-PACIFIC OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 37. ASIA-PACIFIC OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD MILLION)
TABLE 38. ASIA-PACIFIC OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 39. ASIA-PACIFIC OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD MILLION)
TABLE 40. AUSTRALIA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD MILLION)
TABLE 41. AUSTRALIA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 42. AUSTRALIA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD MILLION)
TABLE 43. CHINA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD MILLION)
TABLE 44. CHINA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 45. CHINA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD MILLION)
TABLE 46. INDIA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD MILLION)
TABLE 47. INDIA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 48. INDIA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD MILLION)
TABLE 49. INDONESIA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD MILLION)
TABLE 50. INDONESIA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 51. INDONESIA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD MILLION)
TABLE 52. JAPAN OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD MILLION)
TABLE 53. JAPAN OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 54. JAPAN OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD MILLION)
TABLE 55. MALAYSIA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD MILLION)
TABLE 56. MALAYSIA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 57. MALAYSIA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD MILLION)
TABLE 58. PHILIPPINES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD MILLION)
TABLE 59. PHILIPPINES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 60. PHILIPPINES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD MILLION)
TABLE 61. SINGAPORE OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD MILLION)
TABLE 62. SINGAPORE OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 63. SINGAPORE OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD MILLION)
TABLE 64. SOUTH KOREA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD MILLION)
TABLE 65. SOUTH KOREA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 66. SOUTH KOREA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD MILLION)
TABLE 67. THAILAND OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD MILLION)
TABLE 68. THAILAND OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 69. THAILAND OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD MILLION)
TABLE 70. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 71. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD MILLION)
TABLE 72. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 73. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD MILLION)
TABLE 74. FRANCE OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD MILLION)
TABLE 75. FRANCE OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 76. FRANCE OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD MILLION)
TABLE 77. GERMANY OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD MILLION)
TABLE 78. GERMANY OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 79. GERMANY OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD MILLION)
TABLE 80. ITALY OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD MILLION)
TABLE 81. ITALY OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 82. ITALY OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD MILLION)
TABLE 83. NETHERLANDS OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD MILLION)
TABLE 84. NETHERLANDS OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 85. NETHERLANDS OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD MILLION)
TABLE 86. QATAR OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD MILLION)
TABLE 87. QATAR OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 88. QATAR OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD MILLION)
TABLE 89. RUSSIA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD MILLION)
TABLE 90. RUSSIA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 91. RUSSIA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD MILLION)
TABLE 92. SAUDI ARABIA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD MILLION)
TABLE 93. SAUDI ARABIA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 94. SAUDI ARABIA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD MILLION)
TABLE 95. SOUTH AFRICA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD MILLION)
TABLE 96. SOUTH AFRICA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 97. SOUTH AFRICA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD MILLION)
TABLE 98. SPAIN OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD MILLION)
TABLE 99. SPAIN OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 100. SPAIN OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD MILLION)
TABLE 101. UNITED ARAB EMIRATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD MILLION)
TABLE 102. UNITED ARAB EMIRATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 103. UNITED ARAB EMIRATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD MILLION)
TABLE 104. UNITED KINGDOM OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD MILLION)
TABLE 105. UNITED KINGDOM OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 106. UNITED KINGDOM OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD MILLION)
TABLE 107. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET: SCORES
TABLE 108. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET: BUSINESS STRATEGY
TABLE 109. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET: PRODUCT SATISFACTION
TABLE 110. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET: RANKING
TABLE 111. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 112. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET: MERGER & ACQUISITION
TABLE 113. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 114. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 115. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET: INVESTMENT & FUNDING
TABLE 116. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 117. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • Alkem Laboratories
  • Anika Therapeutics, Inc.
  • Bioventus, Inc.
  • Chugai Pharmaceutical Co., Limited
  • Ferring B.V.
  • Flexion Therapeutics, Inc.
  • Horizon Pharma plc
  • Pfizer Inc
  • Sanofi S.A.
  • Zimmer Biomet Holdings, Inc.
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll